Background We aimed to identify rare (minor allele frequency ≤1%), potentially pathogenic non-synonymous variants in a well-characterised cohort with a clinical history of exertional heat illness (EHI) or exertional rhabdomyolysis (ER). The genetic link between malignant hyperthermia (MH) and EHI was investigated due to their phenotypic overlap. Methods The coding regions of 38 genes relating to skeletal muscle calcium homeostasis or exercise intolerance were sequenced in 64 patients (mostly military personnel) with a history of EHI, or ER and who were phenotyped using skeletal muscle in vitro contracture tests. We assessed the pathogenicity of variants using prevalence data, in silico analysis, phenotype and segregation evidence and by ...
Mutations in the skeletal muscle ryanodine receptor (RYR1) gene are associated with a wide spectrum ...
Malignant hyperthermia (MH) is a dominantly inherited pharmacogenetic condition that manifests as a ...
Malignant hyperthermia (MH) is a pharmacogenetic disorder of skeletal muscle metabolism characterize...
Exertional heat illness (EHI) is a clinically important disorder, notifiable in military personnel, ...
International audienceMalignant hyperthermia susceptibility (MHS) is a subclinical pharmacogenetic d...
Exertional Heat Stroke (EHS) and Malignant Hyperthermia (MH) are life-threatening diseases triggered...
Background: Variants in RYR1 are associated with the majority of cases of malignant hyperthermia (MH...
Some genetic studies have shown a linkage between malignant hyperthermia susceptibility (MHS) and ch...
Mutations in the skeletal muscle ryanodine receptor (RYR1) gene are a common cause of neuromuscular ...
Mutations in the skeletal muscle ryanodine receptor (RYR1) gene are a common cause of neuromuscular ...
Exertional rhabdomyolysis (ER) and stress-induced malignant hyperthermia (MH) events are syndromes t...
Exertional rhabdomyolysis (ER) and stress-induced malignant hyperthermia (MH) events are syndromes t...
Malignant hyperthermia (MH) is an autosomal dominant disorder characterized by abnormal calcium home...
Malignant hyperthermia (MH) is a rare pharmacogenetic disorder in humans caused by inhalational gene...
Mutations in the skeletal muscle ryanodine receptor (RYR1) gene are associated with a wide spectrum ...
Malignant hyperthermia (MH) is a dominantly inherited pharmacogenetic condition that manifests as a ...
Malignant hyperthermia (MH) is a pharmacogenetic disorder of skeletal muscle metabolism characterize...
Exertional heat illness (EHI) is a clinically important disorder, notifiable in military personnel, ...
International audienceMalignant hyperthermia susceptibility (MHS) is a subclinical pharmacogenetic d...
Exertional Heat Stroke (EHS) and Malignant Hyperthermia (MH) are life-threatening diseases triggered...
Background: Variants in RYR1 are associated with the majority of cases of malignant hyperthermia (MH...
Some genetic studies have shown a linkage between malignant hyperthermia susceptibility (MHS) and ch...
Mutations in the skeletal muscle ryanodine receptor (RYR1) gene are a common cause of neuromuscular ...
Mutations in the skeletal muscle ryanodine receptor (RYR1) gene are a common cause of neuromuscular ...
Exertional rhabdomyolysis (ER) and stress-induced malignant hyperthermia (MH) events are syndromes t...
Exertional rhabdomyolysis (ER) and stress-induced malignant hyperthermia (MH) events are syndromes t...
Malignant hyperthermia (MH) is an autosomal dominant disorder characterized by abnormal calcium home...
Malignant hyperthermia (MH) is a rare pharmacogenetic disorder in humans caused by inhalational gene...
Mutations in the skeletal muscle ryanodine receptor (RYR1) gene are associated with a wide spectrum ...
Malignant hyperthermia (MH) is a dominantly inherited pharmacogenetic condition that manifests as a ...
Malignant hyperthermia (MH) is a pharmacogenetic disorder of skeletal muscle metabolism characterize...